Sabate, AngelsEstopa, AssumpcioBorras, JoannaBelmonte, MiquelElsevier Ireland LtdDiabetes Research & Clinical PracticeCosta B, Sabaté A, Estopa A, et al. Lispro or regular insulin for type 1 diabetes treatment with multiple injection therapy? A cost-effectiveness assessment [abstract no. P1293]...
There’s a faster aspart and then lispro-aabc, which is a faster form of insulin lispro. Those are a little bit faster, but they only work a few minutes faster. In terms of duration of action in the body, they still are around the same. Most of their actions are done by 4 hours ...
Insulin lispro shows its worth in type 1 DMThe model showed that the insulin lispro arm would be associated with an increase in mean life expectancy of 0.06 years, and a mean quality-adjusted life-year ( QALY ) increase of 0.105, compared with human insulin. Higher rates of severe ...
Insulin glulisine, insulin lispro and regular human insulin show comparable end-organ metabolic effects: an exploratory study Aims: To compare the end-organ metabolic effects of insulin glulisine (glulisine), insulin lispro (lispro) and regular human insulin (RHI) in patients ... K Horvath,...
We investigated insulin lispro kinetics with bolus and continuous Subcutaneous insulin infusion (CSII) modes of insulin delivery Seven Subjects with type-1 diabetes treated by CSII with insulin lispro have been studied during prandial and postprindial conditions over 12 hours. Eleven alternative models...
OBJECTIVE—Both rapid-acting insulin analogs, insulin aspart and lispro, attenuate prandial glucose excursion compared with human soluble insulin. This trial was performed to study the pharmacokinetic and pharmacodynamic profiles of insulin aspart and insulin lispro in type 1 diabetic patients in a direct...
OBJECTIVE: To measure the effectiveness of insulin lispro, a fast-acting insulin analog, in reducing hypoglycemic episodes when used in a basal bolus regim... SR Heller,SA Amiel,P Mansell - 《Diabetes Care》 被引量: 270发表: 1999年 Improved postprandial glycemic control during treatment with Hu...
Use of insulin Lispro in type 2 diabetes - a 6 month expierienceUse of insulin Lispro in type 2 diabetes - a 6 month expieriencedoi:10.1016/S0168-8227(00)81603-4ElzbietaBandurska-StankiewiczandWiolettaZasadowskaSDOSDiabetes Research & Clinical Practice...
The three currently marketed long-acting insulin analogs, glargine, detemir and insulin lispro protamine suspension (ILPS), represent the most significant advances in basal insulin supplementation since the 1940s and 1950s and the introduction of the intermediate-acting NPH (neutral protamine Hagedorn)...
Top of pageIntroduction Materials and Methods Results Discussion Acknowledgements Conflict of Interest References Aims To compare efficacy and safety of two, once-daily basal insulin formulations [insulin lispro protamine suspension (ILPS) vs. insulin glargine (glargine)] added to oral antihyperglycaemic...